DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

PetMed Express, Inc.

DB:PQM Stock Report

Market Cap: €29.7m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

PetMed Express Management

Management criteria checks 1/4

PetMed Express' CEO is Leslie C. Campbell, appointed in Aug 2025, has a tenure of 1.08 years. total yearly compensation is $830.22K, comprised of 93.3% salary and 6.7% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth €42.36K. The average tenure of the management team and the board of directors is 2.3 years and 1.8 years respectively.

Key information

Leslie C. Campbell

Chief executive officer

US$830.2k

Total compensation

CEO salary percentage93.35%
CEO tenure1.1yrs
CEO ownership0.1%
Management average tenure2.3yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Leslie C. Campbell's remuneration changed compared to PetMed Express's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-US$29m

Mar 31 2026US$830kUS$775k

-US$57m

Dec 31 2025n/an/a

-US$65m

Sep 30 2025n/an/a

-US$55m

Jun 30 2025n/an/a

-US$44m

Mar 31 2025US$78kn/a

-US$6m

Dec 31 2024n/an/a

US$357k

Sep 30 2024n/an/a

-US$963k

Jun 30 2024n/an/a

-US$3m

Mar 31 2024US$143kn/a

-US$7m

Dec 31 2023n/an/a

-US$3m

Sep 30 2023n/an/a

-US$547k

Jun 30 2023n/an/a

US$1m

Mar 31 2023US$203kn/a

US$5m

Dec 31 2022n/an/a

US$9m

Sep 30 2022n/an/a

US$13m

Jun 30 2022n/an/a

US$17m

Mar 31 2022US$338kn/a

US$19m

Dec 31 2021n/an/a

US$22m

Sep 30 2021n/an/a

US$25m

Jun 30 2021n/an/a

US$27m

Mar 31 2021US$274kn/a

US$24m

Dec 31 2020n/an/a

US$31m

Sep 30 2020n/an/a

US$30m

Jun 30 2020n/an/a

US$28m

Mar 31 2020US$160kn/a

US$26m

Compensation vs Market: Leslie C.'s total compensation ($USD830.22K) is above average for companies of similar size in the German market ($USD395.99K).

Compensation vs Earnings: Leslie C.'s compensation has increased whilst the company is unprofitable.


CEO

Leslie C. Campbell (68 yo)

1.1yrs
Tenure
US$830,219
Compensation

Ms. Leslie C. G. Campbell is Executive Chair of the Board of PetMed Express, Inc. She was Independent Chairman of the Board of PetMed Express, Inc. from January 5, 2024 and serves as its Independent Direct...


Leadership Team

NamePositionTenureCompensationOwnership
Leslie C. Campbell
Executive Chairman of the Board1.1yrsUS$830.22k0.14%
€ 42.4k
Douglas Krulik
Chief Accounting Officer2.1yrsUS$426.84k0.36%
€ 107.1k
Robert Lawsky
Corporate Secretary & General Counselno datano datano data
Jacqueline Smith
Vice President of People4.7yrsno data0.076%
€ 22.7k
Caroline Conegliano
Chief Growth Officer2.3yrsno datano data
Wendy Zalai
Corporate Controller & Corporate Secretary5.6yrsno datano data
2.3yrs
Average Tenure

Experienced Management: PQM's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Leslie C. Campbell
Executive Chairman of the Board8.2yrsUS$830.22k0.14%
€ 42.4k
Peter Batushansky
Independent Director1.4yrsUS$146.11k0.44%
€ 129.8k
Justin Mennen
Lead Independent Director2.3yrsUS$161.74k0.47%
€ 138.8k
James LaCamp
Independent Directorless than a yearUS$103.33k0.43%
€ 127.7k
1.8yrs
Average Tenure
43yo
Average Age

Experienced Board: PQM's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/16 07:51
End of Day Share Price 2026/09/16 00:00
Earnings2026/06/30
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PetMed Express, Inc. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Erin Wilson WrightBofA Global Research
Kristine KoerberCitizens JMP Securities, LLC
David WestenbergCL King & Associates, Inc.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide